Patients and family members of those affected by Johnson and Johnson's faulty hip implants gathered in Delhi Saturday demanding they be directly involved in the process of ascertaining the compensation.
They asserted the amount should not only be based on the physical, medical criteria but also take into account the mental, social and economic harm faced by them.
They expressed apprehension that the government could "toe the line" of the pharma giant as it was conducting an one-sided inquiry.
The affected patients said the government was jointly liable as it was neither responsive to the safety concerns associated with the device in other countries nor did it take immediate steps to order a mandatory recall and cancel the license of the firm.
Their demands came in the wake of news reports that the central committee being set up for compensation is likely to meet for the first time on September 18.
The AIDAN, a network of patients working with the patients, called for criminal action against all involved, including people in government who failed to act against the use of such harmful implants.
They also responded to claims of Johnson and Johnson that it has been unable to trace the majority of ASR -- anywhere between 2,400 to 3,700 -- because it did not have access to patient details which were only available to surgeons because of confidentiality.
George Thomas, chief orthopaedic surgeon, St Isabel's Hospital in Chennai said, "All joints for human implantation have stickers which are used to trace the individual joint. As per normal protocols, one of these stickers has to be pasted in the surgical record of the patient. Therefore, it is difficult to believe that the patients cannot be found."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
